UC Physician Appointed to NIH Transplantation Board
Cincinnati--Roy First, MD, director of University of Cincinnati (UC)
Medical Center's Section of Transplantation in the Department of
Internal Medicine's Nephrology and Hypertension Division, was recently
appointed to serve on the National Institutes of Health (NIH) Data and
Safety Monitoring board for transplantation. He will serve a six-year
term on the seven-member board which reviews all NIH approved studies
"This is a prestigious appointment," says First. "NIH is extremely
particular about who they select to review transplantation studies. It
is a great honor to be asked to sit on the board."
First has been a member of the UC College of Medicine faculty since
1974 and has been involved in numerous studies concerning the drugs
used to prevent transplanted organs from being rejected by the body.
"About 1,400 to 1,500 transplants have been performed at University
Hospital, and as a result of the recent advances in cadaver transplants
and antirejection drugs, the one-year success rate has risen to 88
percent," First says.
First was also elected to serve a four-year term as a councilor at a
July meeting of the International Transplantation Society. The
international executive committee--with ten councilors from each
hemisphere--meets every other year and oversees all issues regarding
First has served on many national committees and has published many
articles on transplantation issues. He was a past president of the
American Society of Transplant Physicians and has served on a number of
committees of the United Network of Organ Sharing (UNOS), a
governmental body that oversees organ transplantation in the United
States. He has published 252 papers and has written 28 book chapters in
the field of transplantation.